Back to Search
SHERI LIPPMAN, MD
MD
Pediatrics Physician
NPI: 1770651556Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
036103667(IL)
Research & Publications (20)
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.
PMID 19584075·Cancer Prev Res (Phila)·2009
8-other
Cancer prevention research: back to the future.
PMID 19491288·Cancer Prev Res (Phila)·2009
7-preclinical
Cancer prevention: from 1727 to milestones of the past 100 years.
PMID 19491253·Cancer Res·2009
6-review
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.
PMID 19470930·J Clin Oncol·2009
6-review
Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
PMID 19528369·J Clin Oncol·2009
8-other
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
PMID 19332725·J Clin Oncol·2009
3-trial
Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.
PMID 19318668·Chest·2009
8-other
Nutritional prevention of cancer: new directions for an increasingly complex challenge.
PMID 19276449·J Natl Cancer Inst·2009
8-other
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells.
PMID 19276160·Mol Cancer Ther·2009
4-observational
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.
PMID 19244175·J Natl Cancer Inst·2009
3-trial
Glucose regulates transcription in yeast through a network of signaling pathways.
PMID 19225458·Mol Syst Biol·2009
8-other
Microarray profiling of phage-display selections for rapid mapping of transcription factor-DNA interactions.
PMID 19360118·PLoS Genet·2009
8-other
Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions.
PMID 19197984·Cancer·2009
8-other
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
PMID 19194117·Am J Clin Oncol·2009
3-trial
The changing face of phase 1 cancer clinical trials: new challenges in study requirements.
PMID 19165808·Cancer·2009
4-observational
Cyclin D1 and cancer development in laryngeal premalignancy patients.
PMID 19139013·Cancer Prev Res (Phila)·2009
2-rct
Cancer Prevention Research. Letter from the Editor.
PMID 19139009·Cancer Prev Res (Phila)·2009
8-other
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience.
PMID 19571599·Oncology·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 830 W END CT
VERNON HILLS, IL 60061 - Phone
- (847) 522-8900
Quick Facts
- NPI
- 1770651556
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile